Regeneron Pharmaceuticals, Inc.

Williams Jones Wealth Management, LLC. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

819

Value ($000)

632

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	632	0.0%	819	12/31/2025
2025 Q3	11/14/2025	459	0.0%	817	9/30/2025
2025 Q2	8/14/2025	513	0.0%	978	6/30/2025
2025 Q1	5/15/2025	681	0.0%	1,073	3/31/2025
2024 Q4	2/14/2025	782	0.0%	1,098	12/31/2024
2024 Q3	11/14/2024	1,906	0.0%	1,813	9/30/2024
2024 Q2	8/5/2024	1,908	0.0%	1,815	6/30/2024
2024 Q1	5/7/2024	1,712	0.0%	1,779	3/31/2024
2023 Q4	2/14/2024	1,512	0.0%	1,721	12/31/2023
2023 Q3	11/14/2023	1,486	0.0%	1,806	9/30/2023
2023 Q2	8/14/2023	1,247	0.0%	1,736	6/30/2023
2023 Q1	5/15/2023	1,427	0.0%	1,736	3/31/2023
2022 Q4	2/14/2023	1,253	0.0%	1,736	12/31/2022
2022 Q3	11/14/2022	1,196	0.0%	1,736	9/30/2022
2022 Q2	8/15/2022	1,026	0.0%	1,736	6/30/2022
2022 Q1	5/16/2022	1,202	0.0%	1,721	3/31/2022
2021 Q4	2/14/2022	1,087	0.0%	1,722	12/31/2021
2021 Q3	11/15/2021	1,017	0.0%	1,680	9/30/2021
2021 Q2	8/16/2021	945	0.0%	1,692	6/30/2021
2021 Q1	5/17/2021	891	0.0%	1,884	3/31/2021
2020 Q4	2/16/2021	891	0.0%	1,845	12/31/2020
2020 Q3	11/13/2020	820	0.0%	1,465	9/30/2020
2020 Q2	8/14/2020	754	0.0%	1,209	6/30/2020